MX2022013789A - Aqueous anti microbial composition useful as a therapeutic material. - Google Patents

Aqueous anti microbial composition useful as a therapeutic material.

Info

Publication number
MX2022013789A
MX2022013789A MX2022013789A MX2022013789A MX2022013789A MX 2022013789 A MX2022013789 A MX 2022013789A MX 2022013789 A MX2022013789 A MX 2022013789A MX 2022013789 A MX2022013789 A MX 2022013789A MX 2022013789 A MX2022013789 A MX 2022013789A
Authority
MX
Mexico
Prior art keywords
therapeutic material
composition useful
microbial composition
aqueous anti
anti microbial
Prior art date
Application number
MX2022013789A
Other languages
Spanish (es)
Inventor
Lawrence Carlson
Andrew Yaksic
Patrick Scalera
Anthony Atala
Original Assignee
Tygrus Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tygrus Llc filed Critical Tygrus Llc
Priority claimed from PCT/US2021/030429 external-priority patent/WO2021222884A1/en
Publication of MX2022013789A publication Critical patent/MX2022013789A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

A therapeutic material active against SARS-COV 2 and other microbial pathogens and method of administering the same.
MX2022013789A 2020-05-01 2021-05-03 Aqueous anti microbial composition useful as a therapeutic material. MX2022013789A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202063019258P 2020-05-01 2020-05-01
US202063121856P 2020-12-04 2020-12-04
US202163144305P 2021-02-01 2021-02-01
PCT/US2021/030429 WO2021222884A1 (en) 2020-05-01 2021-05-03 Aqueous anti microbial composition useful as a therapeutic material

Publications (1)

Publication Number Publication Date
MX2022013789A true MX2022013789A (en) 2023-04-19

Family

ID=84783639

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022013789A MX2022013789A (en) 2020-05-01 2021-05-03 Aqueous anti microbial composition useful as a therapeutic material.

Country Status (10)

Country Link
EP (1) EP4142688A1 (en)
JP (1) JP2023524110A (en)
KR (1) KR20230019105A (en)
CN (1) CN116194077A (en)
AU (1) AU2021262868A1 (en)
BR (1) BR112022022273A2 (en)
CA (1) CA3201078A1 (en)
DO (1) DOP2022000241A (en)
IL (1) IL297886A (en)
MX (1) MX2022013789A (en)

Also Published As

Publication number Publication date
AU2021262868A1 (en) 2023-01-19
IL297886A (en) 2023-01-01
KR20230019105A (en) 2023-02-07
EP4142688A1 (en) 2023-03-08
CN116194077A (en) 2023-05-30
DOP2022000241A (en) 2023-09-15
JP2023524110A (en) 2023-06-08
CA3201078A1 (en) 2021-11-04
BR112022022273A2 (en) 2023-01-31

Similar Documents

Publication Publication Date Title
BR112023020442A2 (en) UBIQUITIN-SPECIFIC PROTEASE 1 INHIBITOR (USP1)
NZ701559A (en) Compositions comprising povidone-iodine
NZ600929A (en) Combinations comprising a fungicidal strain and an active compound
FI963232A (en) Acidified nitrite as an antimicrobial agent
AR044007A1 (en) METHODS FOR THE TREATMENT OF PARKINSON'S DISEASE
MX2020013064A (en) Lactobacillus plantarum for skin care.
MX2022006533A (en) A 19-nor c3,3-disubstituted c21-n-pyrazolyl steroid and methods of use thereof.
MX2022001004A (en) Enzyme inhibitors.
MX2022001933A (en) Enzyme inhibitors.
BRPI0916885B8 (en) pharmaceutical composition
PH12019500618A1 (en) Pharmaceutical composition and method for treatment of non-alcoholic fatty liver disease
WO2023081830A3 (en) Compositions and treatments with nirogacestat
CR20230164A (en) Phospholipid compounds and uses thereof
JP2013539776A5 (en)
MX2021015652A (en) Derivative compound introducing biphenyl group into novel aminoalkanoic acid and antifungal pharmaceutical composition comprising same.
BRPI0414822A (en) method of inhibiting the production of remaining lipoprotein
AU2002215982A1 (en) Topical treatment of mastalgia with arometese inhibitors such as androstendione
AU2021391241B2 (en) Lactam-modified polypeptide compounds
MX2022005388A (en) Pyrrolidine and piperidine compounds.
WO2019139956A3 (en) Prevention and treatment of organ fibrosis
MX2022013789A (en) Aqueous anti microbial composition useful as a therapeutic material.
AU2018260628A1 (en) Pharmaceutical composition comprising tryptophan and phyllokinin derivative for use in treating psychiatric and psychological conditions
PH12020551772A1 (en) Oxo-substituted compound
AU2017258649A1 (en) Covalent BTK inhibitors and uses thereof
AR123960A1 (en) COMPOSITIONS COMPRISING SPIRULINA COMPONENTS